Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureHolly Burke, Jessica Mackness, Ekerette Emmanuel Udoh, Andrée Sosler, Helen Anyasi, Mia Buono, Christina Memmott, Ezechukwu I. Nwokoma, Anthony Adindu Nwala
Abstract
Authors
Institutions
No local reference links have been materialized yet.
No local citing links have been materialized yet.
The Levonorgestrel Intrauterine System: Reasons to Expand Access to the Public Sector of Africa.
10.9745/ghsp-d-15-00178 · 2015
The Levonorgestrel Intrauterine System: A Pragmatic View of an Excellent Contraceptive.
10.9745/ghsp-d-15-00330 · 2015
SECOND NATIONAL STRATEGIC HEALTH DEVELOPMENT PLAN 2018–2022.
2018
Barriers and Enablers Influencing Women's Adoption and Continuation of Vaginally Inserted Contraceptive Methods: A Literature Review.
10.1111/sifp.12209 · 2022
Provider and lay perspectives on intra-uterine contraception: a global review.
10.1186/s12978-017-0380-8 · 2017
Implementation science: Scaling a training intervention to include IUDs and implants in contraceptive services in primary care.
10.1016/j.ypmed.2020.106290 · 2020
Acceptability and promotion strategies for LNG-IUS in Ghana: A public health assessment.
10.31899/rh13.1004 · 2009
Expanding Access to a New, More Affordable Levonorgestrel Intrauterine System in Kenya: Service Delivery Costs Compared With Other Contraceptive Methods and Perspectives of Key Opinion Leaders.
10.9745/ghsp-d-15-00327 · 2016
Clinical outcomes of intrauterine device insertions by newly trained providers: The ECHO trial experience.
Provenance
crossref
Confidence 100%
ror
Confidence 99%
ror
Confidence 99%
europepmc
Confidence 96%
unpaywall
Confidence 95%
openalex
Confidence 95%
datacite
Confidence 0%
10.1016/j.conx.2023.100092 · 2023
Reasons for the Low Level of IUD Use in El Salvador.
10.2307/3088272 · 2002
Global Health Supply Chain Program –Procurement and Supply Management.
2021
Subject and clinician experience with the levonorgestrel-releasing intrauterine system.
10.1016/j.contraception.2007.09.006 · 2008
Overcoming barriers to levonorgestrel-releasing intrauterine system placement: an evaluation of placement of LNG-IUS 8 using the modified EvoInserter® in a majority nulliparous population.
10.1016/j.contraception.2017.08.004 · 2017
National Hormonal Intrauterine Device (H-IUD) Introduction and Scale-Up Plan (2021–2024).
Kept as external metadata until matched
Nigeria
2020
Population Services International, and Society for Family Health Announce Launch of Avibela® Hormonal Intrauterine Device in Nigeria.
2022
Hormonal intrauterine device: Facilitator’s guide 2021
2025
How Many Interviews Are Enough?: An Experiment with Data Saturation and Variability.
10.1177/1525822x05279903 · 2006
Factors affecting uptake of the levonorgestrel-releasing intrauterine device: A mixed-method study of social franchise clients in Nigeria.
10.1371/journal.pone.0257769 · 2021
the First Hormone-Free Copper Intrauterine System (IUS) in the U.S. in Over 40 Years, from Sebela Women's Health Inc.
2025
Generalization in quantitative and qualitative research: Myths and strategies.
10.1016/j.ijnurstu.2010.06.004 · 2010
Clinician satisfaction and insertion characteristics of a new applicator to insert radiopaque Implanon: an open-label, noncontrolled, multicenter trial.
10.1016/j.contraception.2010.04.007 · 2010
Uptake of the levonorgestrel intrauterine system among recent postpartum women in Kenya: factors associated with decision-making.
10.1016/j.contraception.2013.03.001 · 2013
No additional external references are available.